Sign in
VINC Stock Price, Chart, Stats & News
Vincerx Pharma, Inc.
Save
Vincerx Pharma, Inc. (VINC) does not currently pay a dividend.
78,514
Market cap
–
Current P/E
–
Forward P/E
VINC chart
About
Health care
Sector
Biotechnology
Industry
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U. S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer.
Similar securities
Based on sector and market capitalization
Report issue